| Malignant Head and Neck Neoplasm altered in cohorts of …ALTERED_INderived200 of 428show all (up to 200) |
|---|
| ← altered in cohorts of | CSMD3 387 / 528 cases (73 %) · ssm · TCGA-HNSC · largest of 5 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 5 | Observed | gdc | graph → |
| ← altered in cohorts of | CDKN2A 384 / 528 cases (73 %) · ssm · TCGA-HNSC · largest of 5 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 5 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM135B 383 / 528 cases (73 %) · ssm · TCGA-HNSC · largest of 5 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 5 | Observed | gdc | graph → |
| ← altered in cohorts of | PLD1 377 / 528 cases (71 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | COL22A1 376 / 528 cases (71 %) · ssm · TCGA-HNSC · largest of 4 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 4 | Observed | gdc | graph → |
| ← altered in cohorts of | CLDN16 374 / 528 cases (71 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | BCL6 373 / 528 cases (71 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IL1RAP 373 / 528 cases (71 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MB21D2 373 / 528 cases (71 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PKHD1L1 373 / 528 cases (71 %) · ssm · TCGA-HNSC · largest of 5 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 5 | Observed | gdc | graph → |
| ← altered in cohorts of | SI 373 / 528 cases (71 %) · ssm · TCGA-HNSC · largest of 5 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 5 | Observed | gdc | graph → |
| ← altered in cohorts of | TP63 373 / 528 cases (71 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | COL14A1 372 / 528 cases (70 %) · ssm · TCGA-HNSC · largest of 3 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 3 | Observed | gdc | graph → |
| ← altered in cohorts of | EIF4G1 372 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MUC4 372 / 528 cases (70 %) · ssm · TCGA-HNSC · largest of 2 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | OSTN 372 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RUBCN 372 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SPATA16 372 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ADCY8 371 / 528 cases (70 %) · ssm · TCGA-HNSC · largest of 3 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 3 | Observed | gdc | graph → |
| ← altered in cohorts of | BDH1 371 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CCDC50 371 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FER1L6 371 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FGF12 371 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LPP 371 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MELTF 371 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NLGN1 371 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PLEC 371 / 528 cases (70 %) · ssm · TCGA-HNSC · largest of 5 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 5 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC7A14 371 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SDHB 66 / 94 cases (70 %) · ssm · hnsc_a5consortium_2025 | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CLDN1 370 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DLG1 370 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GHSR 370 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GMNC 370 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LSG1 370 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MYC 370 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NAALADL2 370 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | P3H2 370 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PAK2 370 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PCYT1A 370 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PYDC2 370 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RTP2 370 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TG 370 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TMEM207 370 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | UTS2B 370 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ACAP2 369 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | APOD 369 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ATP13A3 369 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ATP13A4 369 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CPN2 369 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FNDC3B 369 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FXR1 369 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IQCG 369 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KCNQ3 369 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LRCH3 369 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MFN1 369 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MUC20 369 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MYNN 369 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NRROS 369 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PEX5L 369 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PHF20L1 369 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PIGZ 369 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PPP1R2 369 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SENP5 369 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SMCO1 369 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TFRC 369 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TNFSF10 369 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TNIK 369 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TNK2 369 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TPRG1 369 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | UBXN7 369 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | YEATS2 369 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ACTL6A 368 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ATAD2 368 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ATP11B 368 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM91A1 368 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FBXO45 368 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FYTTD1 368 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KLHL38 368 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LMLN 368 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LRRIQ4 368 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MCF2L2 368 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MECOM 368 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MTBP 368 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NCBP2 368 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NCEH1 368 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | POU5F1B 368 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RNF139 368 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RPL35A 368 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC51A 368 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLITRK3 368 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SST 368 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ST6GAL1 368 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TMEM212 368 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TTC14 368 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | XXYLT1 368 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZDHHC19 368 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SKIL 367 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | BRAF 302 / 507 cases (60 %) · ssm · TCGA-THCA · largest of 5 cohorts | — | — | Thyroid Gland Carcinoma | 5 | Observed | gdc | graph → |
| ← altered in cohorts of | TTN 211 / 515 cases (41 %) · ssm · hnsc_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | OR11H12 104 / 394 cases (26 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM243B 99 / 394 cases (25 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KCNE1B 99 / 394 cases (25 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SMIM11B 99 / 394 cases (25 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SMIM34B 99 / 394 cases (25 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | OR11H1 98 / 394 cases (25 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | POTEH 96 / 394 cases (24 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CNTNAP3C 89 / 394 cases (23 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SPATA31A7 89 / 394 cases (23 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SPATA31A5 88 / 394 cases (22 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NOTCH1 232 / 1,049 cases (22 %) · ssm · acc_2019 · largest of 5 cohorts | — | — | Adenoid Cystic Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FOXD4L5 87 / 394 cases (22 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ANKRD20A4P 85 / 394 cases (22 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CBWD5 84 / 394 cases (21 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FOXD4L4 84 / 394 cases (21 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | POTEM 84 / 394 cases (21 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FRG1BP 106 / 512 cases (21 %) · ssm · hnsc_tcga · largest of 2 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ANKRD20A3P 79 / 394 cases (20 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MUC16 101 / 515 cases (20 %) · ssm · hnsc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZNF658 77 / 394 cases (20 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SPATA31A3 76 / 394 cases (19 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | POTEG 70 / 394 cases (18 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TPTE 68 / 394 cases (17 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ANKRD20A1 67 / 394 cases (17 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CBWD3 67 / 394 cases (17 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM86B2 67 / 394 cases (17 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LINC02203 67 / 394 cases (17 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | POTEB 67 / 394 cases (17 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | POTEB3 67 / 394 cases (17 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | OR4F4 66 / 394 cases (17 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | OR4M2 66 / 394 cases (17 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | OR4N4 66 / 394 cases (17 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LRP1B 85 / 515 cases (17 %) · ssm · hnsc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SYNE1 85 / 515 cases (17 %) · ssm · hnsc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FOXD4L3 65 / 394 cases (16 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SPATA31A6 62 / 394 cases (16 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PCLO 79 / 515 cases (15 %) · ssm · hnsc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DEFB130A 60 / 394 cases (15 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | POTEB2 60 / 394 cases (15 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RRP7A 59 / 394 cases (15 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SHANK3 58 / 394 cases (15 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | WASHC1 58 / 394 cases (15 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CNTNAP3B 56 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DEFB105B 56 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DEFB106B 56 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DEFB107B 56 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM90A10P 56 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM90A17P 56 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM90A19P 56 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM90A8P 56 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM90A9P 56 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TCN2 71 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | THOC5 71 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ADM2 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ALG12 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ARSA 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CCDC117 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CHKB 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CHKB-CPT1B 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CRELD2 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DEFB103B 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DEFB104A 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DEFB104B 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DEFB105A 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DEFB106A 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DEFB107A 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DEFB4B 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM90A16P 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM90A18P 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM90A22P 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM90A23P 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM90A7P 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IL17REL 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KLHDC7B 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LMF2 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MAPK11 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MAPK12 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MIOX 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MLC1 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ODF3B 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PIM3 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PLXNB2 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PPP6R2 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PRR23D1 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SCO2 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SELENOO 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SPAG11A 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SPAG11B 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SYCE3 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TRABD 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TUBGCP6 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TYMP 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZBED4 55 / 394 cases (14 %) · ssm · REBC-THYR | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CELSR1 70 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DEPDC5 70 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EIF4ENIF1 70 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PISD 70 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PLA2G3 70 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RFPL1 70 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SEC14L2 70 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SEC14L4 70 / 507 cases (14 %) · ssm · TCGA-THCA | — | — | Thyroid Gland Carcinoma | 1 | Observed | gdc | graph → |